secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK:        0000879407
Form:       8-K
Filed at:   2023-12-05T23:59:59+00:00
Accession:  0001628280-23-040776
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arrowhead Pharmaceuticals dismisses RSJ as auditor, engages KPMG
----------------------------------------------------------------

- Dismissed Rose, Snyder & Jacobs (RSJ) as independent auditor effective December 1, 2023.
- RSJ's audit reports for FY2022 and FY2023 were unqualified with no adverse opinion.
- No disagreements or reportable events occurred in the two fiscal years or subsequent interim period.
- Engaged KPMG as new independent auditor for fiscal year ending September 30, 2024.
- Company did not consult KPMG on accounting principles, disagreements, or reportable events prior to engagement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879407/000162828023040776/0001628280-23-040776-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879407/000162828023040776/arwr-20231205.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-040776

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer